50-69岁患者生物型主动脉瓣置换的长期结局
该回顾性研究比较50-59岁(n=329)与60-69岁(n=648)首次孤立主动脉瓣置换患者中机械瓣与生物瓣的长期生存。两年龄组长期生存均无差异;50-59岁生物瓣再干预概率更高,60-69岁机械瓣出血并发症更高。
要点
- 两年龄组机械瓣与生物瓣长期生存无差异
- 50-59岁生物瓣15年再干预概率高于机械瓣
- 60-69岁机械瓣15年出血并发症风险高于生物瓣
核心结论
- 50-69岁两年龄组中机械瓣与生物瓣长期生存无差异,可基于生活方式选择生物瓣。
研究设计与样本
- 回顾性分析2000-2019年首次孤立主动脉瓣置换患者,50-59岁n=329、60-69岁n=648,采用Kaplan-Meier与竞争风险分析。
主要发现
- 50-59岁生物瓣再干预概率26.3% vs 机械瓣2.6%(15年,P<0.001)。
- 60-69岁机械瓣出血并发症16.2% vs 生物瓣6.9%(15年,P=0.001)。
- 生物瓣因瓣膜功能障碍总体再干预概率20.9% vs 机械瓣4.8%(P=0.024)。
- 两年龄组出血或血栓栓塞事件发生率相似,长期生存无差异。
临床怎么用
- 50-69岁患者选择瓣膜类型时可结合生活方式偏好,生物瓣不损害长期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There is no consensus regarding the use of biological or mechanical prostheses in patients 50-69 years of age. Previous studies have reported a survival advantage with mechanical valves. Our goal was to compare the long-term survival of patients in the intermediate age groups of 50-59 and 60-69 years receiving mechanical or biological aortic valve prostheses. METHODS: We conducted a retrospective analysis of patients in the age groups 50-59 years (n = 329) and 60-69 years (n = 648) who had a first-time isolated aortic valve replacement between 2000 and 2019. Kaplan-Meier and competing risk analyses were performed to compare survival, incidence of aortic valve reoperation, haemorrhagic complications and thromboembolic events for mechanical versus biological prostheses. RESULTS: Patients aged 50-59 years with a biological prosthesis had a higher probability of aortic valve reintervention (26.3%, biological vs 2.6% mechanical; P < 0.001 at 15 years). The incidence of haemorrhagic complications or thromboembolic events was similar in the 2 groups. Patients aged 60-69 years with a mechanical prosthesis had a higher risk of haemorrhagic complications (6.9%, biological vs 16.2%, mechanical; P = 0.001 at 15 years). Biological prostheses had a higher overall probability of reintervention for valve dysfunction (20.9%, biological vs 4.8%, mechanical; P = 0.024). In both age groups, there was no difference in long-term survival between patients receiving a biological or a mechanical prosthesis. CONCLUSIONS: There was no difference in long-term survival between mechanical and biological prostheses for both age groups. Mechanical prostheses had a higher risk of bleeding in the 60-69-year group whereas biological valves had higher overall reintervention probability without an impact on long-term survival. It may be safe to use biological valves based on lifestyle choices for patients in the 50-69-year age group.
引用
- Malvindi PG, Luthra S, Olevano C, et al. Aortic valve replacement with biological prosthesis in patients aged 50-69 years. Eur J Cardiothorac Surg. 2021. PMID: 33966072. doi:10.1093/ejcts/ezaa429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。